• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Neuronetics

Neuronetics ticks up before hours on mixed-bag Q1 results

May 4, 2021 By Danielle Kirsh

Neuronetics (NSDQ:STIM) posted first-quarter results today that beat the revenue consensus on Wall Street and matched on earnings. The Malvern, Pa.-based company reported losses of -$7.9 million, or -31¢ per share, on sales of $12.3 million for the three months ended March 31, 2021, for a sales growth of 7.08% compared with Q1 2020. Earnings per […]

Filed Under: MassDevice Earnings Roundup, Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: Neuronetics

Neuronetics up on Street-beating Q3 results despite losses

November 3, 2020 By Danielle Kirsh

Neuronetics (NSDQ:STIM) posted third-quarter results today that beat the consensus on Wall Street. The Malvern, Penn.-based company reported losses of $3.4 million, or -18¢ per share, on sales of $12.4 million for the three months ended Sept. 30, for a sales loss of -22.2% compared with Q3 2019. Earnings per share were -18¢, 11¢ ahead of […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Neuronetics

Neuronetics rises on Street-beating Q2

August 4, 2020 By Sean Whooley

Neuronetics (NSDQ:STIM) shares ticked up today on second-quarter losses that managed to top the consensus forecast. The Malvern, Pa.-based psychiatric disorder treatment developer posted losses of $-7.8 million, or -41¢ per share, on sales of $9.7 million for the three months ended June 30, 2020, for a -9.5% bottom-line slide on a sales decline of -41.2%. […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: coronavirus, COVID-19, Neuronetics

Neuronetics slides on missed Q1 projections, withdraws 2020 guidance

May 5, 2020 By Danielle Kirsh

Neuronetics (NSDQ:STIM) posted first-quarter results that missed the consensus forecast on Wall Street. The Malvern, Penn.-based company reported losses of $12.6 million, or -68¢, on sales of $11.5 million for the three months ended March 31, for a bottom-line sales loss of -9.8% compared with Q1 2019. Earnings per share were -68¢, 16¢ behind The Street, […]

Filed Under: Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: Neuronetics

Neuronetics, Obalon Therapeutics get PPP loans

April 28, 2020 By Sean Whooley

Neuronetics (NSDQ:STIM) and Obalon Therapeutics (NSDQ:OBLN) are the latest companies to announce that they entered into loans under the Paycheck Protection Program (PPP). The U.S. Small Business Association administers the PPP as part of the Coronavirus Aid, Relief and Economic Security (CARES) Act. Under the PPP, 75% of the loan proceeds must be used for payroll purposes, […]

Filed Under: Business/Financial News, Funding Roundup, Neurological, Neuromodulation/Neurostimulation, Weight loss Tagged With: coronavirus, COVID-19, Neuronetics, Obalon Therapeutics

Neuronetics president and CEO stepping down

March 9, 2020 By Danielle Kirsh

Neuronetics (NSDQ:STIM) recently announced that president and CEO Christopher Thatcher would be stepping down, effective immediately. Thatcher also resigned as director of the board of directors and his employment is expected through May 1. He will continue to provide transition services and advice to the company. Neuronetics said that Thatcher’s resignation was a mutual agreement and […]

Filed Under: Business/Financial News, Neuromodulation/Neurostimulation Tagged With: Neuronetics

Neuronetics stocks up on Street-beating Q4 results

March 3, 2020 By Danielle Kirsh

Neuronetics (NSDQ:STIM) this week posted fourth-quarter results that beat the consensus forecast on Wall Street. The Malvern, Penn.-based company reported profits of $3 million, or -41¢ per share, on sales of $17.4 million for the three months ended Dec. 31, 2019, for a bottom-line sales growth of 11% compared with Q4 2018. Earnings per share were […]

Filed Under: Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: Neuronetics

Neuronetics shares sink on Q3 losses

November 5, 2019 By Sean Whooley

Neuronetics (NSDQ:STIM) shares were down today on third-quarter results that came up short of the consensus forecast. The Malvern, Pa.–based company — which makes a transcranial magnetic stimulation system to treat major depressive disorder — posted losses of -$6.9 million, or -37¢ per share, on sales of $16 million for the three months ended Sept. 30, […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Neuronetics

Neuronetics inks deal with TMS provider for NeuroStar depression device

October 28, 2019 By Sean Whooley

Neuronetics (NSDQ:STIM) said today that it entered into a partnership with Success TMS to offer Neuronetics’ NeuroStar advanced therapy system as its preferred transcranial magnetic stimulation device across six states. The NeuroStar system is designed to use strong magnetic fields to stimulate areas of the brain associated with mood in the treatment of patients with […]

Filed Under: Business/Financial News, Neurological, Neuromodulation/Neurostimulation Tagged With: Neuronetics, Success TMS

Neuronetics updates patient tracking system

July 29, 2019 By Nancy Crotti

Neuronetics  (NSDQ:STIM) today announced the launch of a patient data management system designed to simplify administrative tasks and enable doctors to spend more time on patient care.  The TrakStar Plus system builds on the Malvern, Penn.-based company’s  TrakStar Cloud platform, designed to help physicians track patients implanted with Neuronetics’ NeuroStar device. Neurostar uses strong magnetic […]

Filed Under: Blog, Business/Financial News, Electronic Medical Records (EMR), Health Information Technology, Neuromodulation/Neurostimulation, News Well Tagged With: Neuronetics

Cutera snags Vyaire Medical’s Mowry for CEO | Personnel Moves, July 9, 2019

July 9, 2019 By Brad Perriello

Cutera (NSDQ:CUTR) said today that it snagged Vyaire Medical CEO David Mowry to be its new CEO, effective immediately. The aesthetic device maker in January fired president & CEO James Reinstein after the company missed expectations for its 2018 top line, naming COO Jason Richey as interim chief executive. Mowry led Tornier to a $3.3 billion […]

Filed Under: Business/Financial News Tagged With: Camstent, Cerner Corp., Cutera Inc., Dentsply Sirona, Inari Medical, Medline Industries Inc., Neuronetics, Ocular Therapeutix, Personnel Moves, Pfizer, Pure Bioscience

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS